HROMADKA, Milan, Zuzana MOTOVSKA, Ota HLINOMAZ, Petr KALA, Ivo VARVAROVSKY, Jaroslav DUSEK, Michal SVOBODA, Jiří JARKOVSKÝ, Frantisek TOUSEK, Pavel JANSKY, Stanislav SIMEK, Marian BRANNY, Jan MROZEK, Roman MIKLÍK, Richard ROKYTA a Petr WIDIMSKY. The relationship between symptom onset-to-needle time and ischemic outcomes in patients with acute myocardial infarction treated with primary PCI Observations from Prague-18 Study. JOURNAL OF CARDIOLOGY. NETHERLANDS: ELSEVIER, 2022, roč. 79, č. 5, s. 1-8. ISSN 0914-5087. Dostupné z: https://dx.doi.org/10.1016/j.jjcc.2021.11.015.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název The relationship between symptom onset-to-needle time and ischemic outcomes in patients with acute myocardial infarction treated with primary PCI Observations from Prague-18 Study
Autoři HROMADKA, Milan (203 Česká republika), Zuzana MOTOVSKA (203 Česká republika, garant), Ota HLINOMAZ (203 Česká republika, domácí), Petr KALA (203 Česká republika, domácí), Ivo VARVAROVSKY (203 Česká republika), Jaroslav DUSEK (203 Česká republika), Michal SVOBODA (203 Česká republika, domácí), Jiří JARKOVSKÝ (203 Česká republika, domácí), Frantisek TOUSEK (203 Česká republika), Pavel JANSKY (203 Česká republika), Stanislav SIMEK (203 Česká republika), Marian BRANNY (203 Česká republika), Jan MROZEK (203 Česká republika), Roman MIKLÍK (203 Česká republika, domácí), Richard ROKYTA (203 Česká republika) a Petr WIDIMSKY (203 Česká republika).
Vydání JOURNAL OF CARDIOLOGY, NETHERLANDS, ELSEVIER, 2022, 0914-5087.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Nizozemské království
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.500
Kód RIV RIV/00216224:14110/22:00128074
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.jjcc.2021.11.015
UT WoS 000821518300009
Klíčová slova anglicky Acute myocardial infarction; Symptoms onset to needle time; Risk stratification; P2Y12 inhibitors; Ischemic endpoints
Štítky 14110115, 14110211, 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 24. 7. 2023 12:57.
Anotace
Objectives: Based on previous studies with clopidogrel, the time between acute myocardial infarction (AMI) symptoms onset and primary percutaneous coronary intervention (PCI) was proven as important prognostic factor. Our aim was to assess the relationship between symptoms onset to needle time (SNT) and procedural results and the occurrence of ischemic endpoints in primary angioplasty patients treated with potent P2Y12 inhibitors. Methods: A total of 1,131 out of 1,230 patients randomized to the Prague-18 study (prasugrel vs. ticagrelor in primary PCI) were divided into a high and a low-risk group. The effect of defined SNT on patients' ischemic endpoints and prognosis by their risk status at admission was tested. Results: The median SNT was 3.2 hours. Longer SNTs resulted in a more frequent incidence of TIMI flow <3 post PCI (p=0.015). There were significant differences in the occurrence of the combined ischemic endpoint among the compared SNT groups at 30 days (p=0.032), and 1 year (p=0.011), with the highest incidence in the <<= 1 h SNT group of patients. "Latecomers" (SNT>4 hs) in the high-risk group experienced more reinfarction within 1 year [OR (95% CI) 3.23 (1.09-9.62) p=0.035]; no difference was found in the low-risk group. Conclusions: In the era of intense antithrombotic medication, stratification of MI patients undergoing primary angioplasty, based on initial ischemic risk assessment affected prognosis more than symptom onset to needle time. Longer time delay was significantly related to increased incidence of ischemic events and all-cause mortality only in patients with high ischemic risk. (C) 2021 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
VytisknoutZobrazeno: 18. 7. 2024 04:31